Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

December 2024

Core topics in this month’s edition include:

  • Alhemo® (concizumab-mtci) – New orphan drug approval
  • Astagraf XL® and Prograf® capsules- Drug recall 
  • Zepbound® (tirzepatide) - New indication

Download PDF

Rx navigation